Tuberculosis News and Research

Latest Tuberculosis News and Research

Celgene announces positive results from first phase III study of apremilast in psoriatic arthritis

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced 52-week results from PALACE 1, the Company's first phase III study in psoriatic arthritis at the European Congress of Rheumatology annual meeting in Madrid, Spain.

12 Jun 2013

Johns Hopkins researchers develop experimental vaccine for TB meningitis

A team of Johns Hopkins researchers working with animals has developed a vaccine that prevents the virulent TB bacterium from invading the brain and causing the highly lethal condition TB meningitis, a disease that disproportionately occurs in TB-infected children and in adults with compromised immune system.

12 Jun 2013

Study explores various strategies, suggests cost-effective options for HIV testing in India

In India most people who are HIV positive don't know it, yet testing and treatment are relatively cheap and available. It would therefore meet international standards of cost-effectiveness - and save millions of lives for decades - to test every person in the billion-plus population every five years according to a new study published in the journal PLoS One.

11 Jun 2013

Duke University is awarded $2M to initiate new clinical research network on antibacterial resistance

Duke University, Durham, N.C., has been awarded $2 million to initiate a new clinical research network focused on antibacterial resistance. Total funding for the leadership group cooperative agreement award could reach up to $62 million through 2019.

4 Jun 2013

New approach may reduce time to identify Salmonella strains, say researchers

A new approach may be able to reduce by more than half the time it takes health officials to identify Salmonella strains, according to researchers in Penn State's College of Agricultural Sciences.

4 Jun 2013

Viewpoints: Scalia's 'boost' to Obamacare; California small biz and insurance exchange; Health law's hidden tax

[L]ast week, a divided court decided Arlington v. FCC, an important victory for Barack Obama's administration that will long define the relationship between federal agencies and federal courts. ... In a powerful and convincing opinion by Justice Antonin Scalia, the court's majority ruled that even when the agency is deciding on the scope of its own authority, it has the power to interpret ambiguities in the law.

1 Jun 2013

Common sugar molecule promising target for development of broad-spectrum vaccine

Developing new vaccines to protect against diseases that plague humans is fraught with numerous challenges-one being that microbes tend to vary how they look on the surface to avoid being identified and destroyed by the immune system. However, researchers from Brigham and Women's Hospital (BWH) have discovered a sugar polymer that is common on the cell surface of several pathogens.

28 May 2013

JPIDS releases consensus statement of Sentinel Project on Pediatric Drug-Resistant Tuberculosis

The Journal of the Pediatric Infectious Diseases Society today released its June issue, which includes a consensus statement of the global Sentinel Project on Pediatric Drug-Resistant Tuberculosis.

22 May 2013

Vitamin C kills drug-resistant TB bacteria in lab

In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis bacteria in laboratory culture.

22 May 2013

TB clinical drug trials in jeopardy due to federal sequestration funding cuts

Innovative and potentially game-changing clinical trials to develop new drug regimens to prevent and treat tuberculosis, the second leading global infectious disease killer, are in jeopardy due to federal "sequestration" funding cuts.

21 May 2013

Government of Equatorial Guinea to improve all hospitals in the country

The government of Equatorial Guinea is working to renovate all the hospitals in the country within the next four years, according to Minister of Health Tomas Mecheba Fernandez Galilea.

18 May 2013

New LAMP malaria test to improve diagnosis for imported UK cases

A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to new research published in the Journal of Infectious Diseases.

17 May 2013

Viewpoints: When a doctor should keep quiet; 2 views of hospital pricing; Stem cell 'snake oil'

In medical school, we were taught not to withhold information from our patients or to be "paternal" in making decisions for them. We internalized the idea that fully informed patients are better equipped to make treatment decisions.

17 May 2013

Viewpoints: A nurse finds getting coordinated care for her husband challenging; Iowa legislator outlines problems with Medicaid; Researcher's quest to save experiments after sandy

In 2011, my husband, Eric, a trial attorney, was felled by a brain stem stroke just before he was to board a flight at O'Hare in Chicago. He was just 53 years old with no prior health conditions or problems. From the outset, we knew his recovery and rehabilitation would be long and difficult. We didn't know that his transition to post-hospital medical care would be just as challenging.

10 May 2013

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

Novartis announced that the US Food and Drug Administration has approved Ilaris (canakinumab) for the treatment of active systemic juvenile idiopathic arthritis in patients aged 2 years and older.

10 May 2013

AHF, KANCO organize NO RETREAT ON AIDS march to call for more global HIV/AIDS funding

Concerned that key partners in the fight against HIV & AIDS like the Global Fund to Fight AIDS, Tuberculosis and Malaria and the President's Emergency Plan for AIDS Relief are losing funding due to government cuts, AIDS Healthcare Foundation, in conjunction with Kenya AIDS NGOs Consortium, have organized a NO RETREAT ON AIDS march from Jevanjee Gardens to Uhuru Park on Friday May 10, 2013 to protest the loss of lifesaving and much-needed funding.

9 May 2013

ITM researchers develop, test a combination of tools to diagnose SN-TB

Researchers at the Institute of Tropical Medicine have successfully developed and tested a combination of simple clinical, radiological and laboratory tools to diagnose smear-negative tuberculosis.

9 May 2013

Cubist receives Fast Track designation from FDA for late-stage antibiotic candidate

Cubist Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted the Company's late-stage antibiotic candidate ceftolozane/tazobactam (CXA-201) Fast Track status in the previously granted Qualified Infectious Disease Product indications, Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia and Complicated Urinary Tract Infections.

8 May 2013

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria.

7 May 2013

Public-private partnerships can help advance global health goals

"Three people die every minute from tuberculosis -- a treatable and largely preventable disease. Resistant forms continue to thrive, and increased travel makes the global threat very real. We face a public health emergency," Vince Forlenza, chair, CEO, and president of the medical technology firm Becton, Dickinson and Company, writes in the Harvard Business Review Blog Network.

3 May 2013

Tuberculosis News and Research

Latest Tuberculosis News and Research

Celgene announces positive results from first phase III study of apremilast in psoriatic arthritis

Johns Hopkins researchers develop experimental vaccine for TB meningitis

Study explores various strategies, suggests cost-effective options for HIV testing in India

Duke University is awarded $2M to initiate new clinical research network on antibacterial resistance

New approach may reduce time to identify Salmonella strains, say researchers

Viewpoints: Scalia's 'boost' to Obamacare; California small biz and insurance exchange; Health law's hidden tax

Common sugar molecule promising target for development of broad-spectrum vaccine

JPIDS releases consensus statement of Sentinel Project on Pediatric Drug-Resistant Tuberculosis

Vitamin C kills drug-resistant TB bacteria in lab

TB clinical drug trials in jeopardy due to federal sequestration funding cuts

Government of Equatorial Guinea to improve all hospitals in the country

New LAMP malaria test to improve diagnosis for imported UK cases

Viewpoints: When a doctor should keep quiet; 2 views of hospital pricing; Stem cell 'snake oil'

Viewpoints: A nurse finds getting coordinated care for her husband challenging; Iowa legislator outlines problems with Medicaid; Researcher's quest to save experiments after sandy

FDA approves Novartis' Ilaris for treatment of active systemic juvenile idiopathic arthritis

AHF, KANCO organize NO RETREAT ON AIDS march to call for more global HIV/AIDS funding

ITM researchers develop, test a combination of tools to diagnose SN-TB

Cubist receives Fast Track designation from FDA for late-stage antibiotic candidate

Aeras receives grant to support the development of vaccines against TB, HIV and malaria

Public-private partnerships can help advance global health goals

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in